Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Angiotensin 2 Type 1 Receptor Antagonists [MoA]

Known as: Angiotensin II Type 1 Receptor Antagonists, Angiotensin 2 Type 1 Receptor Antagonists, Angiotensin II Type I Receptor Blockers 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
  • A. Richards
  • Annals of the Academy of Medicine, Singapore
  • 2015
  • Corpus ID: 26333146
A new treatment for heart failure (HF) combining angiotensin 2 type 1 receptor blockade with inhibition of the widespread… Expand
2013
2013
This editorial refers to ‘Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies’, by S.J… Expand
Review
2012
Review
2012
The metabolic syndrome affects 30% of the US population with increasing prevalence. In this paper, we explore the relationship… Expand
2012
2012
BackgroundBoth angiotensin II type I receptor blockers (ARBs) and calcium channel blockers (CCBs) are widely used… Expand
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
Review
2007
Review
2007
  • F. Zannad, R. Fay
  • Fundamental & clinical pharmacology
  • 2007
  • Corpus ID: 41971695
The aim of the present work was to review published studies investigating the dose‐related efficacy on blood pressure (BP) of… Expand
Review
2005
Review
2005
Recent large clinical trials have shown that angiotensin II type I receptor blockers (ARBs) reduce cardiovascular morbidity and… Expand
2004
2004
Anemia is one of the most serious complications in patients on dialysis. Erythropoietin improves the anemia. However… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • table I
Highly Cited
2003
Highly Cited
2003
OBJECTIVE Angiotensin-converting enzyme (ACE) inhibitor and angiotensin II type I receptor blockers (ARB) prevent cardiac… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2002
2002
Have the theoretical advantages of the angiotensin II receptor blockers become reality for the treatment of chronic heart failure… Expand
2002
2002
  • M. Komajda
  • Heart failure monitor
  • 2002
  • Corpus ID: 10216375
Angiotensin II type I receptor antagonists (ARAs) have been tested in two large randomized trials, Evaluation of Losartan in the… Expand